Particle Therapy Market is expected to increase at a compound annual growth rate (CAGR) of 9.6% from 2025 to 2035

 

The particle therapy market was estimated to be worth USD 2.5 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 9.6% to reach USD 3.6 billion in 2035. Particle therapy lowers the harm to heathy tissue and enhances the disease control. The market is associated with the healthcare industry, which makes it a sustainable and expanding market.

One form of external beam radiation used to treat malignant tumors is particle therapy, which mostly uses proton beams. Particle therapy is also referred to more scientifically as hadron therapy. In this therapy most particle beams radiation is administered in a precise manner and has specific physical features, which reduce the collateral damage to normal tissues. This trait is particularly essential for tumors positioned near critical structures and not spreading to other sections of the body.

 

Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/particle-therapy-market

 

GROWTH DRIVERS

The rise in prevalence of cancer globally is the key primary driver of the market towards expansion. International Agency for Research on Cancer (IARC) 2022 report notes that 20 million new cancer cases and 9.7 million deaths globally, with lung and breast cancer being most common. Furthermore, it is anticipated that the number of cancer cases will rise to 35 million by 2050, especially in low and medium HDI nations, underscoring the necessity of better healthcare infrastructure and access to affordable cancer services.

Additionally, they obtained a USD 1.5 million initial investment from the Wisconsin Alumni Research Foundation and a USD 20 million grant from the National Cancer Institute. The rise in aging population is more incident to cancer where American Cancer Society database indicates that 39.6% of women and 41.6% of men are projected to have cancer over their lifetime. People 65 years of age and older are diagnosed with about two-thirds of all new cases.

MARKET SEGMENTATION: 

·         By Therapy Type- proton therapy (cyclotron and synchrotrons), heavy-ion therapy and hybrid particle therapy  

·         By Room Configuration Type- single room and multi room 

·         By Application- research and treatment 

·         By Cancer Type- pediatric cancer, breast cancer, lung cancer, prostate cancer, colorectal cancer, liver cancer and others 

·         By Region- North America, Europe, Asia Pacific, Middle & Africa and South America

Global Key Players: 

·         IBA Worldwide

·         Varian Medical Systems

·         Hitachi

·         Mevion Medical Systems

·         Optivus Proton Therapy

·         Sumitomo Heavy Industries, Ltd.

·         Danfysik A/S

·         Provision Healthcare

·         Other Players

 

For More Information about this Report @ https://www.xresearch.biz/shop/particle-therapy-market

 

About Us: -  

xResearch is a market research and consulting organization that uses unique data, expert analysis, and new technologies to create trusted intelligence on industries. Our research is focused on delivering an informed and impartial view on essential market data of industry, and it is primarily driven by an in-depth study covering the following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.

                                   

Contact:                                           
Company Name:  xResearch
Contact Person:  James Lin
Email:  sales@xresearch.biz
Phone: +1 718-619-8140

Websites: https://www.xresearch.biz/

 


Comments

Popular posts from this blog

Microalgae Fertilizers Market is expected to increase at a compound annual growth rate (CAGR) of 12.1% from 2025 to 2035

Food Encapsulation Market is predicted to expand at a compounded annual growth rate (CAGR) of 6.8% during the forecast period

Food Thermometer Market is expected to increase at a compound annual growth rate (CAGR) of 15.3% from 2025 to 2035